Literature DB >> 3997895

Tumorigenicity testing of primate cell lines in nude mice, muscle organ culture and for colony formation in soft agarose.

I S Levenbook, J C Petricciani, Y Qi, B L Elisberg, J L Rogers, L B Jackson, D E Wierenga, B A Webster.   

Abstract

Primate neoplastic and finite cell lines were tested in one in vivo and two in vitro test systems: adult nude mice, muscle organ culture (MOC) and soft agarose (SA). Comparison of the sensitivity of the systems indicated that nude mice were inferior to either in vitro system: WI-38 VA13 (an SV40 transformed cell line) did not cause tumours in these animals yet it behaved as if it were neoplastic in MOC and formed colonies in SA. There was complete correlation between results obtained in MOC and SA. All cell lines which produced tumors in vivo were positive in both in vitro test systems. None of the lines which showed normal patterns in MOC and in SA was tumorigenic in nude mice. Since testing in vitro is simpler, faster, and is thought to be reliable, we recommend SA followed by MOC as the initial assays for determining tumorigenicity of cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997895     DOI: 10.1016/s0092-1157(85)80019-6

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  3 in total

1.  Early passage primate cell immortality is independent of tumorigenicity.

Authors:  J C Petricciani; I S Levenbook; D E Wierenga; Y H Qi
Journal:  In Vitro Cell Dev Biol       Date:  1987-07

2.  Proteomic analysis of honeybee (Apis mellifera L.) pupae head development.

Authors:  Aijuan Zheng; Jianke Li; Desalegn Begna; Yu Fang; Mao Feng; Feifei Song
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

3.  Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells.

Authors:  Takuya Kuroda; Satoshi Yasuda; Shinji Kusakawa; Naoya Hirata; Yasunari Kanda; Kazuhiro Suzuki; Masayo Takahashi; Shin-Ichi Nishikawa; Shin Kawamata; Yoji Sato
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.